Cardinal Health, Inc. $CAH Holdings Decreased by Northwestern Mutual Wealth Management Co.

Northwestern Mutual Wealth Management Co. reduced its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 16.8% during the fourth quarter, Holdings Channel.com reports. The firm owned 53,522 shares of the company’s stock after selling 10,819 shares during the period. Northwestern Mutual Wealth Management Co.’s holdings in Cardinal Health were worth $10,999,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Vanguard Group Inc. raised its stake in shares of Cardinal Health by 2.0% during the fourth quarter. Vanguard Group Inc. now owns 31,441,258 shares of the company’s stock valued at $6,461,179,000 after purchasing an additional 617,775 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of Cardinal Health by 0.7% during the fourth quarter. Geode Capital Management LLC now owns 6,529,013 shares of the company’s stock valued at $1,336,750,000 after purchasing an additional 43,924 shares in the last quarter. Wellington Management Group LLP raised its stake in shares of Cardinal Health by 153.2% during the third quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock valued at $911,010,000 after purchasing an additional 3,511,579 shares in the last quarter. Bank of America Corp DE raised its stake in shares of Cardinal Health by 3.2% during the third quarter. Bank of America Corp DE now owns 3,592,775 shares of the company’s stock valued at $563,922,000 after purchasing an additional 111,582 shares in the last quarter. Finally, Invesco Ltd. raised its stake in shares of Cardinal Health by 14.7% during the third quarter. Invesco Ltd. now owns 3,483,207 shares of the company’s stock valued at $546,724,000 after purchasing an additional 445,425 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health Trading Down 0.7%

Shares of CAH opened at $195.33 on Tuesday. The business’s 50-day moving average price is $203.21 and its 200 day moving average price is $208.75. The stock has a market capitalization of $45.75 billion, a P/E ratio of 29.87, a P/E/G ratio of 1.17 and a beta of 0.52. Cardinal Health, Inc. has a 1-year low of $137.75 and a 1-year high of $233.60.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating the consensus estimate of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The company had revenue of $60.94 billion for the quarter, compared to analysts’ expectations of $62.10 billion. During the same quarter in the previous year, the business posted $2.35 EPS. The business’s revenue for the quarter was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, research analysts predict that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.

Cardinal Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be paid a dividend of $0.5158 per share. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $2.06 annualized dividend and a yield of 1.1%. Cardinal Health’s dividend payout ratio (DPR) is presently 31.19%.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on CAH. Wells Fargo & Company cut their price objective on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating on the stock in a research note on Friday, May 1st. Leerink Partners reaffirmed an “outperform” rating and set a $275.00 target price on shares of Cardinal Health in a report on Monday, March 9th. Wall Street Zen lowered Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Saturday. JPMorgan Chase & Co. lowered their target price on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a report on Monday, May 4th. Finally, Barclays lifted their target price on Cardinal Health from $243.00 to $258.00 and gave the stock an “overweight” rating in a report on Tuesday, February 24th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $241.80.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.